rs142329098
Positions:
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP3PP5
The NM_030780.5(SLC25A32):c.440G>A(p.Arg147His) variant causes a missense change. The variant allele was found at a frequency of 0.000171 in 1,612,240 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.00020 ( 0 hom., cov: 31)
Exomes 𝑓: 0.00017 ( 0 hom. )
Consequence
SLC25A32
NM_030780.5 missense
NM_030780.5 missense
Scores
13
5
1
Clinical Significance
Conservation
PhyloP100: 5.56
Genes affected
SLC25A32 (HGNC:29683): (solute carrier family 25 member 32) This gene encodes a member of the P(I/L)W subfamily of mitochondrial carrier family transport proteins. The encoded protein transports folate across the inner mitochondrial membrane. Alternatively spliced transcript variants have been described. [provided by RefSeq, Mar 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 4 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.823
PP5
Variant 8-103403276-C-T is Pathogenic according to our data. Variant chr8-103403276-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 223106.We mark this variant Likely_pathogenic, oryginal submissions are: {Likely_pathogenic=1, Uncertain_significance=2}. Variant chr8-103403276-C-T is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SLC25A32 | NM_030780.5 | c.440G>A | p.Arg147His | missense_variant | 4/7 | ENST00000297578.9 | |
SLC25A32 | NR_102337.2 | n.524G>A | non_coding_transcript_exon_variant | 3/6 | |||
SLC25A32 | NR_102338.2 | n.719G>A | non_coding_transcript_exon_variant | 5/8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SLC25A32 | ENST00000297578.9 | c.440G>A | p.Arg147His | missense_variant | 4/7 | 1 | NM_030780.5 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000204 AC: 31AN: 151812Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
31
AN:
151812
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000716 AC: 18AN: 251262Hom.: 0 AF XY: 0.0000589 AC XY: 8AN XY: 135820
GnomAD3 exomes
AF:
AC:
18
AN:
251262
Hom.:
AF XY:
AC XY:
8
AN XY:
135820
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000168 AC: 245AN: 1460314Hom.: 0 Cov.: 30 AF XY: 0.000168 AC XY: 122AN XY: 726560
GnomAD4 exome
AF:
AC:
245
AN:
1460314
Hom.:
Cov.:
30
AF XY:
AC XY:
122
AN XY:
726560
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000204 AC: 31AN: 151926Hom.: 0 Cov.: 31 AF XY: 0.000215 AC XY: 16AN XY: 74264
GnomAD4 genome
AF:
AC:
31
AN:
151926
Hom.:
Cov.:
31
AF XY:
AC XY:
16
AN XY:
74264
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
1
ALSPAC
AF:
AC:
1
ESP6500AA
AF:
AC:
1
ESP6500EA
AF:
AC:
3
ExAC
AF:
AC:
11
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:2Uncertain:2
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Exercise intolerance, riboflavin-responsive Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | MGZ Medical Genetics Center | Aug 24, 2021 | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Oct 12, 2020 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Dec 15, 2023 | Variant summary: SLC25A32 c.440G>A (p.Arg147His) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 7.2e-05 in 251262 control chromosomes (gnomAD). c.440G>A has been reported in the literature in an individual affected with Exercise Intolerance, Riboflavin-Responsive who was compound heterozygous with a truncating variant (Schiff_2016). These data do not allow any conclusion about variant significance. This publication also reports experimental evidence evaluating an impact on protein function in a yeast model, finding that the missense variant in the orthologous protein results in significantly reduced enzymatic activity. The following publication has been ascertained in the context of this evaluation (PMID: 26933868). Three submitters have cited clinical-significance assessments for this variant to ClinVar after 2014, and classified it as pathogenic (n=1), likely pathogenic (n=1), or uncertain significance (n=1). Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 21, 2024 | This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 147 of the SLC25A32 protein (p.Arg147His). This variant is present in population databases (rs142329098, gnomAD 0.04%). This missense change has been observed in individual(s) with recurrent exercise intolerance (PMID: 26933868). ClinVar contains an entry for this variant (Variation ID: 223106). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SLC25A32 protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change affects SLC25A32 function (PMID: 26933868). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Pathogenic
DEOGEN2
Uncertain
D;.
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D
M_CAP
Uncertain
D
MetaRNN
Pathogenic
D;D
MetaSVM
Pathogenic
D
MutationAssessor
Pathogenic
H;.
MutationTaster
Benign
D;D
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D;.
REVEL
Pathogenic
Sift
Pathogenic
D;.
Sift4G
Pathogenic
D;.
Polyphen
D;.
Vest4
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at